Gwenola Bougras Selected Research

O-acetyl-GD2 ganglioside

6/2013	Cell cycle arrest and apoptosis induced by O-acetyl-GD2-specific monoclonal antibody 8B6 inhibits tumor growth in vitro and in vivo.
1/2011	A monoclonal antibody to O-acetyl-GD2 ganglioside and not to GD2 shows potent anti-tumor activity without peripheral nervous system cross-reactivity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gwenola Bougras Research Topics

Disease

8	Neoplasms (Cancer) 10/2014 - 09/2002
2	Osteolysis 04/2013 - 01/2012
1	Osteosarcoma (Osteogenic Sarcoma) 10/2014
1	Neoplasm Metastasis (Metastasis) 10/2014
1	Ewing Sarcoma (Sarcoma, Ewing) 04/2013
1	Bone Resorption 04/2013
1	Osteoporosis 01/2012
1	Neuroblastoma 01/2011
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2008
1	Epstein-Barr Virus Infections 02/2008
1	Carcinoma (Carcinomatosis) 09/2004
1	Melanoma (Melanoma, Malignant) 09/2002

Drug/Important Bio-Agent (IBA)

3	AntigensIBA 06/2013 - 09/2002
2	O-acetyl-GD2 gangliosideIBA 06/2013 - 01/2011
2	Monoclonal AntibodiesIBA 06/2013 - 01/2011
2	Neoplasm Antigens (Tumor Antigens)IBA 09/2004 - 09/2002
2	Proteins (Proteins, Gene)FDA Link 08/2004 - 09/2002
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2014
1	SD-208IBA 10/2014
1	EWS-FLI fusion proteinIBA 04/2013
1	Connexin 43 (Connexin43)IBA 04/2013
1	Transcription Factors (Transcription Factor)IBA 04/2013
1	Heparin (Liquaemin)FDA LinkGeneric 01/2012
1	Proteoglycans (Proteoglycan)IBA 01/2012
1	GD2 gangliosideIBA 01/2011
1	CytokinesIBA 09/2006
1	Transforming Growth Factor beta (TGF-beta)IBA 09/2004
1	MART-1 AntigenIBA 09/2002
1	HLA-A*02:01 antigenIBA 09/2002
1	Peptides (Polypeptides)IBA 09/2002

Therapy/Procedure

2	Immunotherapy 06/2013 - 09/2002
1	Drug Therapy (Chemotherapy) 03/2008
1	Therapeutics 09/2004